Earlier this year a collaboration effort was established with the NIH to determine the role of microRNAs in HIV viral replication, and their potential to act as novel drug targets for future therapy, and with the purchase of Parkway Clinical Labs this year, there’s a lot going on here.
Stay tuned as next week I’ll have an interview posted with a discussion with one of the key members of the Rosetta team. BD
The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia.
miRview meso differentiates mesothelioma, a cancer connected to asbestos exposure, from other carcinomas in the lung, the company said.
Rosetta Genomics expects to perform approximately 2,000 tests during 2009 in its laboratory in Philadelphia, Pennsylvania.
Rosetta Genomics introduces new cancer test - Pharmaceutical Business Review









![EZClaim[4] EZClaim[4]](http://lh4.ggpht.com/_v3zjJigoAPE/TG1-9etl5ZI/AAAAAAAAgqg/CRMlet5Pi5k/EZClaim44.png?imgmax=800)













Math–This Could be a Subject for Michael Moore to Explore and Document In a Movie


Duping” Society Combined With A World of Rogue Algorithms & Flawed Data Continues In Markets As Seen With Knight Capital This Week-Attack of the Killer Algorithms Chapter 36
Study Fraud With EHR Technologies, Namely Medical Records/Billing Software Used by Hospitals– HHS And SEC Continue Getting Their Non-Algorithmic Fannies Kicked–Attack of the Killer Algorithms Chapter 46
SilverScript Senior Drug Program Sanctioned by Medicare Until the Payment And Billing Algorithms are Cleaned Up-Killer Algorithms Chapter 53
